{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:05:20Z","timestamp":1790737520909,"version":"4.1.0"},"reference-count":45,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003762","name":"Institut Pasteur","doi-asserted-by":"publisher","award":["E024519"],"award-info":[{"award-number":["E024519"]}],"id":[{"id":"10.13039\/501100003762","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sant\u00e9 Publique France","award":["E02498"],"award-info":[{"award-number":["E02498"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>Invasive meningococcal disease (IMD) is classically associated with meningitis and septic shock, but an increasing proportion of cases present with atypical, extra-meningeal manifestations. Following the COVID-19 pandemic, major epidemiological shifts have occurred in France, including a rebound in IMD incidence and changes in circulating serogroups and clonal complexes. We conducted a nationwide retrospective study including all laboratory-confirmed IMD cases analysed by the French National Reference Centre between July 2014 and June 2025. Clinical presentations were coded as non-exclusive entities. Associations with age, serogroup, clonal complex, antimicrobial susceptibility and early mortality (\u226472 h) were assessed using descriptive analyses and multivariable logistic regression models. Among 4328 IMD cases, sepsis\/shock (61.1%) and meningeal involvement (54.9%) predominated, while atypical forms were frequent, including bacteraemic pneumonia (7.7%), abdominal presentations (8.0%) and arthritis (6.0%). Bacteraemic pneumonia was strongly associated with older age and serogroups W and Y, whereas abdominal forms predominated in adolescents and young adults and were independently associated with serogroups W and Y and clonal complex (cc) cc11. Abdominal presentations were independently associated with early mortality (adjusted odds ratio [aOR] 2.40) but not meningococcal pneumonia. Abdominal presentations were associated with serogroup W (aOR 2.27; 95% CI 1.35\u20133.83) and serogroup Y (aOR 2.92; 95% CI 1.79\u20134.75) and with cc11 (aOR 1.77; 95% CI 1.07\u20132.94). In contrast, cc23 was associated with lower odds of abdominal involvement (aOR 0.42; 95% CI 0.25\u20130.70). Overall, atypical presentations now represent a substantial proportion of IMD in France and are strongly shaped by age and meningococcal lineage. These findings highlight diagnostic challenges, prognostic heterogeneity and the need for continued integrated clinical, microbiological and genomic surveillance in the context of evolving vaccination strategies.<\/jats:p>","DOI":"10.3390\/microorganisms14020356","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T10:48:01Z","timestamp":1770115681000},"page":"356","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Changing Clinical Spectrum of Invasive Meningococcal Disease in France (2014\u20132025): Impact of Age and Meningococcal Lineage on Atypical Presentations"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3702-910X","authenticated-orcid":false,"given":"Samy","family":"Taha","sequence":"first","affiliation":[{"name":"Invasive Bacterial Infections Unit, National Reference Centre for Meningococci and Haemophilus Influenzae, Institut Pasteur, Universit\u00e9 Paris Cit\u00e9, 28 rue du Dr Roux, CEDEX 15, 75724 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2887-1732","authenticated-orcid":false,"given":"Ala-Eddine","family":"Deghmane","sequence":"additional","affiliation":[{"name":"Invasive Bacterial Infections Unit, National Reference Centre for Meningococci and Haemophilus Influenzae, Institut Pasteur, Universit\u00e9 Paris Cit\u00e9, 28 rue du Dr Roux, CEDEX 15, 75724 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0716-3174","authenticated-orcid":false,"given":"Muhamed-Kheir","family":"Taha","sequence":"additional","affiliation":[{"name":"Invasive Bacterial Infections Unit, National Reference Centre for Meningococci and Haemophilus Influenzae, Institut Pasteur, Universit\u00e9 Paris Cit\u00e9, 28 rue du Dr Roux, CEDEX 15, 75724 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200105033441807","article-title":"Meningococcal disease","volume":"344","author":"Rosenstein","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1016\/j.vaccine.2018.02.038","article-title":"Epidemiology, clinical presentation, risk factors, intensive care admission and outcomes of invasive meningococcal disease in England, 2010\u20132015","volume":"36","author":"Parikh","year":"2018","journal-title":"Vaccine"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.apjtm.2017.10.004","article-title":"Meningococcal disease, a clinical and epidemiological review","volume":"10","author":"Batista","year":"2017","journal-title":"Asian Pac. J. Trop. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/23744235.2021.1971289","article-title":"Global epidemiology and changing clinical presentations of invasive meningococcal disease: A narrative review","volume":"54","author":"Deghmane","year":"2022","journal-title":"Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/jinf.2000.0719","article-title":"Acute meningococcaemia complicated by late onset gastrointestinal vasculitis","volume":"41","author":"Seaton","year":"2000","journal-title":"J. Infect."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.idcr.2018.02.009","article-title":"Pericarditis due to Neisseria meningitidis serogroup W135","volume":"12","author":"Shinha","year":"2018","journal-title":"IDCases"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"B64","DOI":"10.1016\/j.vaccine.2009.04.061","article-title":"Meningococcal carriage and disease--population biology and evolution","volume":"27","author":"Caugant","year":"2009","journal-title":"Vaccine"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1086\/379719","article-title":"The role of particular strains of Neisseria meningitidis in meningococcal arthritis, pericarditis, and pneumonia","volume":"37","author":"Vienne","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/cid\/ciy257","article-title":"Unusual initial abdominal presentations of invasive meningococcal disease","volume":"67","author":"Guiddir","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.jinf.2017.02.011","article-title":"Characteristics and changes in invasive meningococcal disease epidemiology in France, 2006\u20132015","volume":"74","author":"Deghmane","year":"2017","journal-title":"J. Infect."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Deghmane, A.-E., and Taha, M.-K. (2022). Changes in Invasive Neisseria meningitidis and Haemophilus influenzae Infections in France during the COVID-19 Pandemic. Microorganisms, 10.","DOI":"10.3390\/microorganisms10050907"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Guedes, S., Bertrand-Gerentes, I., Evans, K., Coste, F., and Oster, P. (2022). Invasive meningococcal disease in older adults in North America and Europe: Is this the time for action? A review of the literature. BMC Public Health, 22.","DOI":"10.1186\/s12889-022-12795-9"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s15010-022-01928-2","article-title":"Primary septic arthritis of the knee caused by Neisseria meningitidis serogroup B in an elderly patient. Case report and review of the literature","volume":"51","author":"Longo","year":"2023","journal-title":"Infection"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1080\/17843286.2022.2107315","article-title":"Meningococcal pericarditis caused by the MenW:cc11 strain in an older adult","volume":"78","author":"Moerman","year":"2023","journal-title":"Acta Clin. Belg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.1017\/S0950268821001035","article-title":"Atypical presentation of Neisseria meningitidis serogroup W disease is associated with the introduction of the 2013 strain","volume":"149","author":"Sall","year":"2021","journal-title":"Epidemiol. Infect."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1017\/S0950268819002152","article-title":"Atypical presentation of invasive meningococcal disease caused by serogroup W meningococci","volume":"148","author":"Stinson","year":"2020","journal-title":"Epidemiol. Infect."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.3201\/eid2607.181941","article-title":"Case Manifestations and Public Health Response for Outbreak of Meningococcal W Disease, Central Australia, 2017","volume":"26","author":"Sudbury","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jinf.2019.11.001","article-title":"Variable clinical presentation by the main capsular groups causing invasive meningococcal disease in England","volume":"80","author":"Campbell","year":"2020","journal-title":"J. Infect."},{"key":"ref_19","first-page":"116","article-title":"Massive diarrhoea sepsis due to an infection with Neisseria meningitidis serogroup, W","volume":"77","author":"Houweling","year":"2019","journal-title":"Neth. J. Med."},{"key":"ref_20","first-page":"e39\u201341","article-title":"Abdominal acute pain as initial symptom of invasive meningococcus serogroup A illness","volume":"109","year":"2011","journal-title":"Arch. Argent. Pediatr."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Taha, S., Deghmane, A.E., and Taha, M.K. (2024). Recent increase in atypical presentations of invasive meningococcal disease in France. BMC Infect. Dis., 24.","DOI":"10.1186\/s12879-024-09547-y"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.jiph.2023.10.001","article-title":"The rapid rebound of invasive meningococcal disease in France at the end of 2022","volume":"16","author":"Taha","year":"2023","journal-title":"J. Infect. Public Health"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/jac\/dkw400","article-title":"Emergence of meningococci with reduced susceptibility to third-generation cephalosporins","volume":"72","author":"Deghmane","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_24","unstructured":"(2025, December 05). Breakpoint Tables for Interpretation of MICs and Zone Diameters. Version 15.0. Available online: https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/v_15.0_Breakpoint_Tables.pdf."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/jac\/47.3.285","article-title":"Polymorphism of Neisseria meningitidis penA gene associated with reduced susceptibility to penicillin","volume":"47","author":"Antignac","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1093\/bioinformatics\/btp163","article-title":"Biopython: Freely available Python tools for computational molecular biology and bioinformatics","volume":"25","author":"Cock","year":"2009","journal-title":"Bioinformatics"},{"key":"ref_27","unstructured":"(2025, December 05). Infections Invasives \u00e0 M\u00e9ningocoque en France en 2024. Bulletin National. Avril 2025. Available online: https:\/\/www.santepubliquefrance.fr\/maladies-et-traumatismes\/maladies-a-prevention-vaccinale\/infections-invasives-a-meningocoque\/documents\/bulletin-national2\/infections-invasives-a-meningocoque-en-france-en-2024."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nrmicro.2016.178","article-title":"A journey into the brain: Insight into how bacterial pathogens cross blood-brain barriers","volume":"15","author":"Coureuil","year":"2017","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jinf.2015.07.007","article-title":"Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage","volume":"71","author":"Lucidarme","year":"2015","journal-title":"J. Infect."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Pizza, M., Bekkat-Berkani, R., and Rappuoli, R. (2020). Vaccines against Meningococcal Diseases. Microorganisms, 8.","DOI":"10.3390\/microorganisms8101521"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/j.vaccine.2017.03.007","article-title":"The epidemiology of invasive meningococcal disease in EU\/EEA countries, 2004\u20132014","volume":"35","author":"Whittaker","year":"2017","journal-title":"Vaccine"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s40121-021-00468-w","article-title":"Healthcare Resource Consumption and Cost of Invasive Meningococcal Disease in France: A Study of the National Health Insurance Database","volume":"10","author":"Taha","year":"2021","journal-title":"Infect. Dis. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"493","DOI":"10.7326\/0003-4819-82-4-493","article-title":"Primary meningococcal pneumonia","volume":"82","author":"Irwin","year":"1975","journal-title":"Ann. Intern. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s41479-019-0062-0","article-title":"Meningococcal pneumonia: A review","volume":"11","author":"Feldman","year":"2019","journal-title":"Pneumonia"},{"key":"ref_35","first-page":"1","article-title":"Meningococcal Disease in Older Adults: Challenges in Diagnosis and Management","volume":"15","author":"Taha","year":"2025","journal-title":"Infect. Dis. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.rmr.2025.04.004","article-title":"Update of guidelines for management of Community Acquired pneumonia in adults by French Infectious Disease Society (SPILF) and the French Speaking Society of Respiratory Diseases (SPLF). Endorsed by French intensive care society (SRLF), French microbiology society (SFM), French radiology society (SFR), French emergency society (SFMU)","volume":"42","author":"Dinh","year":"2025","journal-title":"Rev. Mal. Respir."},{"key":"ref_37","first-page":"001530","article-title":"Microevolution associated with clonal expansion of a hypervirulent, penicillin-resistant lineage of Neisseria meningitidis in Western Australia","volume":"11","author":"Mikucki","year":"2025","journal-title":"Microb. Genom."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Willerton, L., Lucidarme, J., Walker, A., Lekshmi, A., Clark, S.A., Walsh, L., Bai, X., Lee-Jones, L., and Borrow, R. (2021). Antibiotic resistance among invasive Neisseria meningitidis isolates in England, Wales and Northern Ireland (2010\/11 to 2018\/19). PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0260677"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1016\/j.vaccine.2021.03.002","article-title":"Increase in penicillin-resistant invasive meningococcal serogroup W ST-11 complex isolates in England","volume":"39","author":"Willerton","year":"2021","journal-title":"Vaccine"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s10096-020-04114-0","article-title":"Antibiotic susceptibility and molecular analysis of invasive Neisseria meningitidis recovered in the Republic of Ireland, 1996 to 2016","volume":"40","author":"Bennett","year":"2021","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Deghmane, A.E., Hong, E., and Taha, M.K. (2023). Recent Evolution of Susceptibility to Beta-Lactams in Neisseria meningitidis. Antibiotics, 12.","DOI":"10.3390\/antibiotics12060992"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1099\/0022-1317-51-10-855","article-title":"Fatal outcome from meningococcal disease--an association with meningococcal phenotype but not with reduced susceptibility to benzylpenicillin","volume":"51","author":"Trotter","year":"2002","journal-title":"J. Med. Microbiol."},{"key":"ref_43","unstructured":"(2025, December 03). Avis n 2025.0040\/AC\/SESPeV du 17 Juillet 2025 Relatif \u00e0 L\u2019ajout des Vaccins Contre les Maladies M\u00e9ningococciques A, C, W, Y et B dans la Strat\u00e9gie Vaccinale. Available online: https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2025-07\/avis_n2025.0040_ac_sespev_17_juillet_2025_college_has_a_lajout_des_vaccins_contre_les_maladies_meningococciques_a_c_w_y_b_la.pdf."},{"key":"ref_44","unstructured":"(2025, December 03). Calendrier Vaccinal et Recommandations Vaccinales 2025. Available online: https:\/\/sante.gouv.fr\/prevention-en-sante\/preserver-sa-sante\/vaccination\/calendrier-vaccinal."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Jolley, K.A., and Maiden, M.C. (2010). BIGSdb: Scalable analysis of bacterial genome variation at the population level. BMC Bioinform., 11.","DOI":"10.1186\/1471-2105-11-595"}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/14\/2\/356\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T11:01:17Z","timestamp":1770116477000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/14\/2\/356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":45,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["microorganisms14020356"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms14020356","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]}}}